Philip H Elsinga Selected Research

SA5845

12/2005

Evaluation of [11C]SA5845 and [11C]SA4503 for imaging of sigma receptors in tumors by animal PET.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philip H Elsinga Research Topics

Disease

44	Neoplasms (Cancer) 05/2022 - 02/2002
9	Inflammation (Inflammations) 01/2021 - 04/2004
8	Prostatic Neoplasms (Prostate Cancer) 04/2021 - 08/2011
8	Glioma (Gliomas) 02/2014 - 04/2004
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2016
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 09/2021 - 09/2008
3	Melanoma (Melanoma, Malignant) 03/2022 - 12/2003
3	Atherosclerotic Plaque (Atheroma) 04/2020 - 01/2013
3	Cognitive Dysfunction 01/2018 - 08/2011
3	Neoplasm Metastasis (Metastasis) 01/2006 - 12/2003
2	Carcinoma (Carcinomatosis) 03/2022 - 12/2005
2	Brain Diseases (Brain Disorder) 12/2021 - 03/2008
2	Asthma (Bronchial Asthma) 01/2021 - 01/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2020
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018 - 07/2004
2	Epilepsy (Aura) 01/2018 - 01/2017
2	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 10/2014
2	Atherosclerosis 12/2015 - 01/2013
2	Memory Disorders (Memory Loss) 06/2015 - 08/2011
2	Sleep Deprivation 06/2015 - 04/2015
2	Neuroinflammatory Diseases 05/2014 - 03/2012
2	Islet Cell Adenoma (Islet Cell Tumors) 05/2012 - 03/2008
2	Laryngeal Neoplasms (Laryngeal Cancer) 12/2009 - 02/2004
2	Schizophrenia (Dementia Praecox) 07/2009 - 01/2004
2	Carcinoid Tumor (Carcinoid) 03/2008 - 09/2006
1	Neurobehavioral Manifestations 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 11/2021
1	Carcinogenesis 01/2021

Drug/Important Bio-Agent (IBA)

12	LigandsIBA 10/2015 - 11/2004
11	RadiopharmaceuticalsIBA 01/2021 - 02/2002
9	sigma Receptors (sigma Receptor)IBA 10/2015 - 11/2004
7	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2017 - 02/2004
6	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2008
6	Pharmaceutical PreparationsIBA 01/2022 - 11/2004
6	SA 4503IBA 06/2015 - 11/2004
5	Bombesin Receptors (Bombesin Receptor)IBA 01/2017 - 08/2011
5	BombesinIBA 01/2017 - 08/2011
5	GlucuronidaseIBA 11/2012 - 05/2010
5	alovudineIBA 01/2011 - 02/2004
4	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022 - 01/2010
4	EnzymesIBA 09/2021 - 05/2010
4	Proteins (Proteins, Gene)FDA Link 04/2017 - 12/2005
4	fluorodopa F 18IBA 01/2015 - 09/2006
4	Peptides (Polypeptides)IBA 10/2013 - 08/2011
4	Adrenergic Receptors (Adrenergic Receptor)IBA 03/2008 - 01/2004
3	Matrix Metalloproteinases (MMPs)IBA 10/2015 - 01/2013
3	Sigma-1 ReceptorIBA 06/2015 - 08/2011
3	ProdrugsIBA 11/2012 - 05/2010
3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2012 - 09/2006
3	TurpentineIBA 03/2012 - 04/2004
3	Haloperidol (Haldol)FDA LinkGeneric 12/2008 - 11/2004
2	AntibodiesIBA 03/2022 - 05/2021
2	Dopamine (Intropin)FDA LinkGeneric 09/2021 - 09/2015
2	Amino Acids FDA Link 09/2021 - 01/2008
2	AzidesIBA 04/2021 - 08/2020
2	Alkynes (Acetylenes)IBA 04/2021 - 08/2020
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 04/2020
2	Cholinergic Agents (Cholinergics)IBA 01/2019 - 08/2011
2	Antineoplastic Agents (Antineoplastics)IBA 10/2015 - 01/2010
2	Adenosine (Adenocard)FDA LinkGeneric 05/2014 - 08/2011
2	Propranolol (Inderal)FDA LinkGeneric 02/2014 - 03/2008
2	bombesin (7-14)IBA 10/2013 - 08/2011
2	Technetium (Technetium 99m)IBA 10/2013 - 08/2011
2	tricineIBA 10/2013 - 08/2011
2	rimcazoleIBA 09/2013 - 12/2008
2	Cytostatic AgentsIBA 11/2012 - 05/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2012 - 03/2007
2	Cisplatin (Platino)FDA LinkGeneric 01/2011 - 09/2006
2	CatecholaminesIBA 10/2009 - 03/2008
2	Carbidopa (Lodosyn)FDA LinkGeneric 09/2008 - 09/2006
2	Phenylalanine (L-Phenylalanine)FDA Link 09/2008 - 03/2008
2	Somatostatin Receptors (Somatostatin Receptor)IBA 03/2008 - 09/2006
2	Choline (Choline Chloride)IBA 01/2008 - 02/2002
2	NucleosidesIBA 01/2008 - 04/2004
2	1- (4- 2'- fluoroethoxy- 3- methoxyphenethyl)- 4- (3- (4- fluorophenyl)propyl)piperazineIBA 01/2006 - 11/2004
2	ThymidineIBA 04/2004 - 12/2003
1	Therapeutic UsesIBA 04/2022
1	IsotopesIBA 03/2022
1	Epithelial Cell Adhesion MoleculeIBA 03/2022
1	Fluorescein (Funduscein)FDA LinkGeneric 03/2022
1	AntigensIBA 03/2022
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 01/2022
1	Histamine AgonistsIBA 01/2022
1	6- ((3- cyclobutyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepin- 7- yl)oxy)- N- methyl- 3- pyridinecarboxamideIBA 01/2022
1	CanagliflozinIBA 11/2021
1	Sodium-Glucose Transport ProteinsIBA 11/2021
1	Carboxy-LyasesIBA 09/2021
1	Alanine (L-Alanine)FDA Link 09/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	ArginaseIBA 01/2021
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 01/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	enzalutamideIBA 01/2021
1	LipidsIBA 04/2020

Therapy/Procedure

12	Therapeutics 05/2021 - 12/2003
4	Drug Therapy (Chemotherapy) 11/2012 - 09/2006
3	Immunotherapy 05/2022 - 01/2018
3	Radiotherapy 10/2013 - 12/2009
1	Secondary Prevention 04/2020